Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mark FitzGerald

Showing results (311-320 of 325) with videos related to

Pageof 33
Sort By:
The European Respiratory Journal|July 26, 2024
Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trialGail M Gauvreau, Roma Sehmi, J Mark FitzGerald, et al.
Chest|November 14, 2021
Bronchial Thermoplasty in Patients With Severe Asthma at 5 Years: The Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma StudyGeoffrey Chupp, Joel N Kline, Sumita B Khatri, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 5, 2018
Development of the International Severe Asthma Registry (ISAR): A Modified Delphi StudyLakmini Bulathsinhala, Nevaashni Eleangovan, Liam G Heaney, et al.
Canadian Respiratory Journal|March 23, 2006
Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPDLouis-Philippe Boulet, Allan Becker, Dennis Bowie, et al.
Journal of Asthma and Allergy|January 20, 2022
Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE StudyAndrew N Menzies-Gow, Claire McBrien, Bindhu Unni, et al.
Chest|April 22, 2021
Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma CohortLiam G Heaney, Luis Perez de Llano, Mona Al-Ahmad, et al.
BMC Medical Research Methodology|August 22, 2020
International severe asthma registry (ISAR): protocol for a global registryJ Mark FitzGerald, Trung N Tran, Marianna Alacqua, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 27, 2023
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthmaLuis Perez-de-Llano, Ghislaine Scelo, G Walter Canonica, et al.
Journal of Asthma and Allergy|October 28, 2022
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic TherapyWenjia Chen, Mohsen Sadatsafavi, Trung N Tran, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 6, 2022
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe AsthmaCeleste M Porsbjerg, Andrew N Menzies-Gow, Trung N Tran, et al.
Pageof 33

Showing results (311-320 of 325) with videos related to

Sort By:
Pageof 33
The European Respiratory Journal|July 26, 2024
Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trialGail M Gauvreau, Roma Sehmi, J Mark FitzGerald, et al.
Chest|November 14, 2021
Bronchial Thermoplasty in Patients With Severe Asthma at 5 Years: The Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma StudyGeoffrey Chupp, Joel N Kline, Sumita B Khatri, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 5, 2018
Development of the International Severe Asthma Registry (ISAR): A Modified Delphi StudyLakmini Bulathsinhala, Nevaashni Eleangovan, Liam G Heaney, et al.
Canadian Respiratory Journal|March 23, 2006
Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPDLouis-Philippe Boulet, Allan Becker, Dennis Bowie, et al.
Journal of Asthma and Allergy|January 20, 2022
Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE StudyAndrew N Menzies-Gow, Claire McBrien, Bindhu Unni, et al.
Chest|April 22, 2021
Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma CohortLiam G Heaney, Luis Perez de Llano, Mona Al-Ahmad, et al.
BMC Medical Research Methodology|August 22, 2020
International severe asthma registry (ISAR): protocol for a global registryJ Mark FitzGerald, Trung N Tran, Marianna Alacqua, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 27, 2023
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthmaLuis Perez-de-Llano, Ghislaine Scelo, G Walter Canonica, et al.
Journal of Asthma and Allergy|October 28, 2022
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic TherapyWenjia Chen, Mohsen Sadatsafavi, Trung N Tran, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 6, 2022
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe AsthmaCeleste M Porsbjerg, Andrew N Menzies-Gow, Trung N Tran, et al.
Pageof 33